← Eichor
Study identifier: NCT07130526 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Distrupt Stiffness Trial

Condition: PAD - Peripheral Arterial Disease · PAD  ·  Sponsor: University Hospital, Essen

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Typical symptoms of PAD include exercise-induced pain in the legs (known as intermittent claudication), which can significantly limit pain-free walking. In more advanced stages, pain may also occur at rest. Additionally, the development of chronic, hard-to-heal wounds-especially on the feet and toes-is possible. These wound healing impairments are caused by the insufficient supply of oxygen and nutrients to the affected tissues. The underlying cause of PAD is usually atherosclerosis, a pathological change in the vessel walls due to the accumulation of fats, calcium, and connective tissue. These deposits lead to stiffening and narrowing of the arteries, severely restricting blood flow. Major risk factors for the development of PAD include widespread chronic conditions such as diabetes mellitus, hyperlipidemia (elevated blood lipid levels, e.g., cholesterol), arterial hypertension (high blood pressure), obesity, and tobacco use. Various therapeutic options are available for the treatment of PAD. In addition to conservative therapy (such as supervised exercise training, pharmacological blood thinning, and risk factor management), interventional, minimally invasive treatment using catheter-based techniques is frequently employed. In such procedures, a thin catheter is guided through the vascular system to the affected area of the leg artery. Depending on the type and extent of the arterial narrowing or calcification, one of the following techniques may be applied: Balloon angi…

This description comes directly from the study's public registry record.

Talk to the study team

Christos Rammos, Prof. Dr. med.  ·  0201-723-4801  ·  christos.rammos@uk-essen.de

Daniel Messiha, Dr. med.  ·  0201-723-4801  ·  daniel.messiha@uk-essen.de

Always discuss trial participation with your own doctor first.

Locations (2)

West German Heart and Vascular Center, Clinic for Cardiology and Vascular Medicine, Universtiy Hospital EssenEssen, North Rhine-Westphalia, GermanyNot Yet Recruiting
University of Duisburg-EssenEssen, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07130526